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Abstract
Background: Cryopreservation is the only widely applicable method of storing vital cells for nearly unlimited periods 
of time. Successful cryopreservation is essential for reproductive medicine, stem cell research, cord blood storage and 
related biomedical areas. The methods currently used to retrieve a specific cell or a group of individual cells with 
specific biological properties after cryopreservation are quite complicated and inefficient.
Results: The present study suggests a new approach in cryopreservation, utilizing the Individual Cell-based Cryo-Chip 
(i3C). The i3C is made of materials having appropriate durability for cryopreservation conditions. The core of this 
approach is an array of picowells, each picowell designed to maintain an individual cell during the severe conditions of 
the freezing - thawing cycle and accompanying treatments. More than 97% of cells were found to retain their position 
in the picowells throughout the entire freezing - thawing cycle and medium exchange. Thus the comparison between 
pre-freezing and post-thawing data can be achieved at an individual cell resolution. The intactness of cells undergoing 
slow freezing and thawing, while residing in the i3C, was found to be similar to that obtained with micro-vials. 
However, in a fast freezing protocol, the i3C was found to be far superior.
Conclusions: The results of the present study offer new opportunities for cryopreservation. Using the present 
methodology, the cryopreservation of individual identifiable cells, and their observation and retrieval, at an individual 
cell resolution become possible for the first time. This approach facilitates the correlation between cell characteristics 
before and after the freezing - thawing cycle. Thus, it is expected to significantly enhance current cryopreservation 
procedures for successful regenerative and reproductive medicine.
Background
With an increasing interest in regenerative medicine, the
preservation of living cells has grown in importance
throughout biomedical science and the pharmaceutical
industry. Cryopreservation is at the moment the only
method to preserve living animal/human cells over a long
time and it is a method widely applicable in diverse bio-
medical disciplines, such as reproductive medicine, stem
cell research, peripheral and umbilical cord blood
cryobanks [1], in the conservation of genetic material
from different species [2]. In all these experimental and
medical areas, the retrieval of a specific cell or a group of
individual cells having particular biological properties is
the ultimate objective of the cryopreservation process.
Successful cryopreservation of such specific cells is
essential for their use in cell-based therapy and research.
There is currently a variety of well-documented cryo-
preservation protocols [3-7] which have been developed
since the discovery of the cryoprotective effect of glycerol
[8], dimethyl sulfoxide [9], and 1,2-propandiol which is
now frequently used for freezing human gametes [10].
Even though most of these protocols are routinely used,
they are incomplete with regard to the survival, function-
ality, and loss of the thawed cells. These drawbacks might
be crucial when the cells are rare (e.g., bio-manipulated
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cells), and/or highly valuable (umbilical cord blood stem
cells, etc.). New experimental techniques and approaches
have also been recently developed [11].
As a rule of thumb, the less media exchange the cells
experience (while transferring cells between vials con-
taining different media in the process of cryopreserva-
tion), the less cell loss there is [12,13]. Nevertheless, in
cases when the identity of a cell must be secured through-
out the freezing - thawing cycle [14], cryopreservation at
a resolution of a single cell must be performed, wherein
each cell is stored in a specific macro-vial. In the latter
case, the procedure becomes time-consuming, as it takes
time to locate the cell in its macro-vial, seize it and trans-
fer it to the next vial. In the cryopreservation of pluripo-
tent and embryonic stem cells, the ability to retrieve a
specific colony is crucial both for research and clinical
applications, since the characteristics of the cells change
during culturing [15] and it is essential to preserve undif-
ferentiated cells [16].
Obviously, if medium exchange can be performed with-
out dislodging/transferring the cells, keeping them in the
same primer vial, and if the cells' identity can be secured
during these manipulations and throughout the freezing -
thawing cycle, e.g. by arresting them, but without inter-
ference with their retrieval, then most of the drawbacks
of cryopreservation could be overcome. Furthermore,
keeping the cells in the same container but spatially sepa-
rated enables them to maintain chemical cell-cell com-
munication, hence there are no negative effects of cell
micro-cultivation.
The present study proposes a new methodology for
cryopreservation, using a single macro-vial, in which the
medium can be exchanged while maintaining the identity
of non-tethered cells before, during and after the freezing
- thawing cycle. The proposed methodology is realized
via the Individual Cell Cryo-Chip (iCCC/i3C), which was
developed in the course of the present study. The i3C
enables optical online monitoring, as well as the tracking
and retrieving of single cells and colonies. In the present
study, the i3C methodology was applied to human pro-
monocytic U937 cells only. However, our intention is to
implement an adjusted device for the cryopreservation of
oocytes and embryos. It will be based on the same meth-
odology but will be adjusted to accommodate large cells.
Results
The Individual Cell Cryo-Chip (iCCC/i3C)
The i3C concept relies on our previous work [17]. How-
ever, the i3C was designed and constructed to accommo-
date the requirements of cryopreservation, namely the
freezing and thawing conditions, and to adjust to cryo-
preservation equipment generally and to cryo-micros-
copy in particular. The i3C (Figure 1) is a "lab on a chip"
capable of retaining cell identity during bio-manipula-
tions and cryopreservation, under continuous micro-
scopic observation. The core of the device is a densely
packed 2-D array of Pico-liter Wells (picowells), etched
onto a 0.5 mm thick glass in a honeycomb pattern (Figure
1). The latter is a part of a capillary microfluidics system.
Each picowell is designed to accommodate a single cell,
thus it is shaped with the dimensions of 20 μm opening
diameter, 8 μm depth and 20 μm pitch. The picowells'
internal surface is smooth, preventing light scattering; its
bottom is nearly flat, minimally diverting the wave front
of the transmitted light, thus making it optically inert for
any practical purposes. In other words, objects located in
the picowells can be viewed via a variety of light (upright
or inverted) microscopy approaches, including transmit-
ted light (bright field, also enabling tracing unstained
cells) and fluorescent light, Differential Interference Con-
trast (DIC), confocal microscopy, two/multi Photon Exal-
tation (2PE), etc.
The edges of picowells' walls are sharp (< 0.5 μm in
their top/edge), augmenting the surface hydrophilic
property and causing the precipitating cells to settle
inside the wells rather than in between. The 6 sides of the
hexagonal picowell are semi-lunar to allow for the flow of
solutions between picowells, while confining each cell
within its particular picowell.
The picowells-bearing glass chip is embedded under a
0.7 mm deep, φ2 mm cylindrical aperture drilled into an
engraved polycarbonate plate, to form the cell chamber.
The i3C includes about 7800 picowells of 20 μm. The i3C
dimensions (28 × 30 × 2.2 mm3) were adjusted to fit the
internal dimensions of the cryogenic microscope stage
used in this study, enabling the glass substrate to attach
directly and fully to the cryo-stage's cooling element (the
silver block shown in F igure 2A). T he assembly of the
picowell substrate to the i3C body is demonstrated in Fig-
ure 3.
Materials were selected to withstand the freezing cycles
demonstrated here: the i3C body is made of mold-
injected polycarbonate with a glass transition tempera-
ture of Tg ~ -135°C; the glass substrate is made of high
quality BK7 glass. The method of glass to plastic bonding
was selected to provide the necessary flexibility required
to bridge the difference in their thermal expansion coeffi-
cients (polycarbonate: ~70 μm/°C, glass: ~7 × 10-6/°C).
Partially flexible medical-grade UV adhesive was used to
attach the chip to the bottom of the polycarbonate base,
to form the cell chamber (loctite 3321, service tempera-
ture -55°C). This adhesive is applied only to set the bond-
ing, but does not perfectly seal the connection. The final
seal is done with PDMS (GE silicones RTV 655, service
temperature ~-115°C) as follows: liquid PDMS is poured
around the glass substrate, and penetrates any gapsDeutsch et al. BMC Cell Biology 2010, 11:54
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between the substrate and polycarbonate base. After heat
curing (+ 80°C for 1 hour), the PDMS is vulcanized and
forms a perfect seal.
After its assembly, the i3C is packed in a tyvek pouch
(Figure 4A) and sterilized in ETO (ethylene oxide) gas.
Cell loading and administration of solutions into the i3C
The entire procedure is usually performed in a sterilized
environment (e.g., sterilized hood, etc.). After removing
the i3C from its pouch, its cell chamber is exposed by
sliding the cover slip (170 μm thick), and a 7.5 μl suspen-
sion of U937 cells in PBS (1.5 - 2 × 106 cells/ml) is poured
into it. As the volume of the chamber is about 2.5 μl, a
localized spherical drop (of about 5 μl) is formed on top
of the cell chamber opening. The cell suspension in the
chamber is left for 7 - 10 minutes to allow for cell sedi-
mentation onto the picowell-padded bottom of the cham-
ber. Next, 5 μl of the PBS supernatant (the upper
protruding spherical drop) is removed, allowing for the
closure of the cover slip, by gently sliding the slip without
moisturizing it, leaving a 0.15 mm gap between the cover
slip and the conduit.
Next, to insure a complete PBS exchange by the cryo-
preservation medium (10% Me2SO in complete medium),
3 - 4 times the chamber volume (2.5 μl × 3 or 5) is intro-
duced on top of the front basin, against the space
between the open conduit and the cover slip. The intro-
duced medium, via capillary forces developed between
the open conduit plane and the cover slip above it, travels
between the two, along the chamber opening towards the
i3C waste area (maximum volume of 30 μl). Through
local turbulences developed near the chamber edges, as
well as diffusion, the medium reaches the cell layer at the
chamber bottom, replacing the remainder of the former
buffer.
The end result of this procedure, whether performed in
the cryostage or externally, is that cells are suspended in
the cryopreservation medium, within the i3C, ready for
the next step of incubation in pre-cooling conditions, for
Figure 1 The i3C and its main components: (1) - cylindrical sample chamber with a bottom made of glass picowells substrate (B and C - SEM 
micrographs), (2) - elevated flow conduit and its front basin, (3) - two engraved longitudinal grooves, (4) - the sliding cover slip (orange), 
(5) - waste accumulation area. Note the reference mark pointed to by the yellow arrow in panel C.Deutsch et al. BMC Cell Biology 2010, 11:54
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further observations, and for undergoing the freezing -
thawing cycle. The major steps of cell loading into the i3C
and medium exchange are shown in Figure 4. These steps
are applicable both within and outside of the cryostage.
Finally, regarding the efficiency of cell loading into
picowells, their occupancy and cluster formation in the
picowells, observations conducted on a total of 6800
picowells, using cell concentrations of 3.5 × 106 cells/ml,
demonstrated the following: (a) Single-cell occupancy
rates were estimated to be 93 ± 2.8% of all the cells
located in the picowells. (b) The average percentage of
the occupied picowells was about 81 ± 4.2% when 7000
cells were loaded. (c) The distributions of cell occupancy
throughout the picowells area and cell-to-cell proximities
were found to be homogenous. (d) No cell clusters were
observed in occupied picowells. (e) No cell clumping was
observed when using non-adherent cells. (f) The coeffi-
cient of variance (CV) of cell occupancy measured on 17
different zones within the area of picowells in the chip
was 5.1%.
Evaluation of the i3C ability to retain cells during the 
freezing - thawing cycle
The cell retaining performance of the i3C during the
freezing - thawing cycle was evaluated by monitoring the
same cells throughout the cycle using an epifluorescence
microscope (Eclipse 80i, Nikon, Japan) which was modi-
fied to include a cryostage (MDBCS 600, Linkam Instru-
Figure 2 A) Open cryostage, the lid (1) is detached, the i3C (2, cloudy structure) is attached via its adaptor (3, metal frame around the i3C) 
to the cooling element (4, circular silver body). (B): The lid is closed. Dry nitrogen gas pipe is in place (5). The sample in the i3C is ready to undergo 
a freezing - thawing cycle. Centers of the lid's window (through which images are acquired - light coming from the condenser is seen) and the i3C's 
bottom are overlapping and situated on the microscope optical axis. (C) Cross section of the i3C placed on the cryo-stage silver cooling element (1) 
ready for experiment. The i3C polycarbonate body (2) hosts the glass picowells chip (3) which is secured to its place by bonding. Bottoms are aligned 
for a perfect contact with the flat cryo-stage. Cells and media (4) which were previously loaded into the i3C are trapped in the cell chamber and the 
flow conduit due to the capillary action of the sliding cover slip (5). The cryo-stage lid is then closed so that the center of its window (6) and microscope 
objective (7) optical axis are overlapping to facilitate microscopic observation of cells in the i3C. Note that for the sake of clarity the colors of the i3C 
components here match those appearing in Figure 1A.Deutsch et al. BMC Cell Biology 2010, 11:54
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ments, UK) instead of the regular object table of the
microscope. The microscope was equipped with a 100 W
Hg fluorescence excitation lamp (LH-m100c-1, Nikon,
Japan) and the following fluorescence cubes (excitation
filters, dichroic mirrors and emission filters respectively):
for fluorescein - 465-495 nm, 505 nm, 515-555 nm, for
Hoechst 33342 - 340-380 nm, 400 nm, 435-485 nm, and
for PI - 540-580 nm, 595 nm, 600-660 nm.
The silver block of the cryostage (Figure 2) was cooled
with liquid nitrogen and heated with an electric heating
wire. Temperature was controlled by a thermo-sensor.
The control of the heating and cooling rate was per-
formed by a TP94 controller which is connected to a PC.
Liquid nitrogen was provided by an external Dewar flask
and a liquid nitrogen pump LNP2. For microscopic
observation, special objectives are necessary due to the
high working distance. Magnifications of 4×, 10×, 20×
and 50× were used, where SLWD-objectives provided
20× and 50× magnifications. The i3C was designed to
ensure the attachment of the picowells substrate to the
silver body, while enabling the conveying, via external
adjustment screws, of the field of picowells to the obser-
vation area (Figure 2). Nevertheless, the i3C and the cells
in it have no direct contact with liquid nitrogen. The only
component in the cryostage that is cooled by direct con-
tact with liquid nitrogen is the silver block. This is done
internally, via pipes that are carved into the silver cooler,
through which the liquid nitrogen is pumped via an
external source.
For convenient cell tracing, U937 cells were first (before
loading into the i3C) vitally stained with the dyes Hoechst
33342 and QD which label the cell nucleus and the cyto-
plasm, respectively. A single experiment yielded at least 5
couples of transmitted and fluorescence light images, all
of the same field of picowells (20 × 20 picowells), yet each
image couple was acquired at a different stage of the
experiment: (a) just after cell loading, (b) after closing the
microscope lid and pre-cooling, (c) just after thawing, (d)
after opening the cryostage lid, in preparation for
medium exchange and (e) after post-thawing medium
exchange. Dislodged cells were counted by comparing the
different groups of images at the individual cell resolu-
tion. Images were acquired by the 14-bit ORCA II C4742-
98 camera (Hamamatsu, Japan) or PL-A662 - 10 bit RGB
color CCD camera (PixeLink, Canada) and analyzed by
the cell^R imaging software (Olympus, Japan).
Sample freezing
After 10 minutes of the stage pre-cooling to 4°C, the first
image was acquired and the freezing procedure initiated.
A fast cooling rate of 40°C per minute was chosen for one
set of experiments and a slow cooling rate of 1°C per min-
ute for another. The freezing end point was -80°C.
Thawing was performed as fast as possible [18]. Gener-
ally, thawing continues for less than 3 minutes for full liq-
uefaction. Within the cryostage, the thawing of samples
stored either in the i3C or in cryo-mini-vials was always
performed controllably: the heating rates were set
Figure 3 Attachment of the glass picowells substrate to the i3C base. (A) The base (1) is placed upside down, and the picowells substrate (2) is 
gently placed in its socket (3, niche) with its picowells facing down the lower entrance of the cell chamber (4). Next (B): Medical grade UV adhesive 
(dashed blue) is gently injected in the empty space created between the chip edge and the niche wall, then irradiated and cured. Then, a small drop 
of liquid PDMS (green) is gently poured near the free edges, and is drawn by capillary forces to fill the empty space between the peripheral face of 
the chip and the bottom of the niche. The PDMS does not penetrate into the cell chamber area (yellow) due to lack of capillary forces in this open 
region. When PDMS is cured, the structure is practically sealed to fluids and withstands freezing - thawing cycles.Deutsch et al. BMC Cell Biology 2010, 11:54
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between 40°C and 30°C per minute. The thawing of sam-
ples that were frozen in a standard NALGENE Cryo 1°C
Freezing Container was conducted by placing the frozen
sample in an incubator at 37°C for 3 minutes. On the
average, the latter procedure quite reliably imitates the
thawing conditions within the cryo-stage, as the tempera-
ture of the frozen sample is elevated from -80° to + 37° in
3 minutes.
Three types of control experiments for the freezing -
thawing cycle were performed, each under a different
setup. The use of the cryo-stage for either fast or slow
freezing control measurements was limited to cryo-mini-
vials due to space restrictions. Nevertheless, slow freez-
ing could also be performed within a macro-vial in a
cryobox.
In order to achieve the best results with the common
cryopreservation, while comparing them with the i3C
approach, the ideal conditions for the former were cho-
sen. Therefore, cell suspension without Me2SO was not
considered as a control, and in all control experiments
the cell pellet was suspended in the cryopreservation
medium (culture medium and Me2SO), incubated for 10
minutes at 4°C, transferred to the freezing device and
then subjected to the freezing - thawing cycle. After
thawing, the cell suspension was transferred to a 15 ml
standard conic tube, and 1-10 ml of fresh complete
medium with 20% FCS was added. The cells were imme-
diately washed by centrifugation, and cell viability was
optically examined via the i3C:
a) Cells were frozen according to the slow freezing pro-
cedure in standard cryo-vials (1 ml cell suspension in the
cryopreservation medium) as well as in a non-transpar-
ent HDPE cryo-mini-well described earlier [19] (Micro-
Cryo well plates, 30 × 25 μl and 9 × 250μl, Fraunhofer
IBMT, Germany, 20 μl of cell suspension in the cryo-
preservation medium). In both cases, freezing was con-
ducted in a standard NALGENE Cryo 1°C Freezing
Container (Thermo Fisher Scientific Inc., Waldham, MA,
USA) at the rate of about 1°C per minute until reaching -
80°C in the Revco Refrigerator (Legaci Refrigeration Sys-
tem, Ashville, NC, USA). Thawing was performed over 3
minutes at 37°C by either placing the sample in an incu-
bator or by immersing it in a water bath.
Figure 4 Working with the i3C: (A) Packed chip in a sterile pouch. (B) The cover glass is moved back enabling the cell suspension to be loaded 
into the chamber. The glass is then closed to cover the chamber and to create a short capillary traction area over the input basin (C), so additional 
aliquots can be added and replace the cell media. Aliquots can be added until the waste area is full and there is no room for additional liquids to enter 
(D). See text for specific volumes and procedures.
A B
D CDeutsch et al. BMC Cell Biology 2010, 11:54
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In summary, cells experiencing slow freezing were cry-
opreserved for:
1. 15 minutes while in cryo-micro well (in cryostage), 
and while in cryo-vial (in cryobox) and for
2. 4 days while in cryo-micro well and in cryo-vial (all 
stored in cryobox).
3. Moreover, cells in the i3C were either kept frozen 
for 15 minutes within the cryostage or for up to 4 days 
within the cryobox.
Next, whatever permutations of comparison made
between these 6 conditions listed in clauses 1-3, no
observable difference was found with reference to post-
thawing results groups. Data was analyzed utilizing the
ANOVA test for small sample groups. b) Cells were fro-
zen according to the fast freezing procedure, while resid-
ing in a non-transparent HDPE cryo-mini-well described
earlier [19] (Micro-Cryo well plates, 30 × 25 μl and 9 ×
250 μl, 20 μl of cell suspension in the cryopreservation
medium). The entire process was carried out in the tem-
perature-controlled cryostage. Thawing was performed
in the cryostage as described above.
c) As a principal control, cells from the same culture
flask were used, omitting the freezing - thawing cycle.
In all the above cases, cell viability was examined under
the same optical conditions, within the i3C, as described
above.
Finally, it should be emphasized that, when sterile con-
ditions are required, then after cell loading into a steril-
ized i3C in a sterilized environment, the loaded i3C is
placed into a container, where it is maintained hermeti-
cally sealed and sterile during freezing and cryopreserva-
tion, either in a Revco refrigerator or in an atmosphere of
liquid nitrogen. However, in the present study, even
though the cell-loaded i3C can be sterile, the freezing that
is performed directly in the cryostage of a cryomicro-
scope (in contrast to Revco or liquid nitrogen dewar) is
conducted in a non-sterile environment. Nevertheless,
arrangements can be made to ensure sterility in the cry-
ostage. Even though the importance of sterility for long
i3C preservation is obvious, we did not find it critically
necessary to assess the feasibility of the i3C methodology.
Cell retrieval
When the i3C cover slip is open, cells can be retrieved
from their picowells by a micromanipulator (e.g., Eppen-
dorf, TransferMan NK2 micromanipulators from Eppen-
dorf, NY, USA, see Additional File 1). However, when
sliding the glass cover slip to expose the cell chamber
opening for cell retrieval, fluids and cells might be uncon-
trollably evacuated from the chamber due to adhesion
forces between the fluid and the cover glass. This prob-
lem was overcome in three ways.
First, only the upper layer of the chamber content that
touches the cover slip was thawed, by warming the slip
(e.g., by gently touching it from above with a finger) and
simultaneously pulling it back, separating the slip from
the rest of the frozen content in the chamber and above it.
Next, while the slip is open, the thawing of the rest of the
frozen content continues without dislodging the cells
from their original locations, the cells thus being accessi-
ble for retrieval.
Second, thawing was allowed to occur with a closed
slip. Then, the slip was opened by applying an intense,
short impact on the slip edge in parallel to the slip's
movement slots. The sudden thrust pushes the slip back,
while the chamber content remains undisturbed due to
its inertia and consequently the cells were not dislodged.
A simple means to accomplish this was by releasing the
head trigger of a ball point pen spring.
Third, while the slip covers the chamber, the open
space between the slip and the i3C's surface was flooded
with PBS. Next, the slip was pushed to expose the cham-
ber opening for cell retrieval. Flow formation and conse-
quent cell dislodging during the slip movement is
prevented, as there is no empty space to be filled by flu-
ids.
Feasibility study
In slow biological freezing or vitrification processes, all
materials exposed to the stressful conditions of cryo-
preservation must withstand these stresses without
breakage or leakage. Matter usually expands with increas-
ing temperature and contracts with its decrease. The het-
erogeneous cooling/heating of a composite material with
different expansion factors causes thermo-mechanical
stress. This stress can cause material damage or loss of
connection. Furthermore, material elasticity usually
decreases with a decreasing temperature, making the
material more brittle and vulnerable to other mechanical
stresses, such as simple touch or manual/automatic
transfer procedures. The durability of the PW substrate
and of the i3C body in the severe conditions of cryo-
preservation was tested as follows.
Durability of the picowell glass substrate
Ten glass picowell substrates were challenged in an
intense temperature shock cycling test: First, while car-
ried in a metal receptacle, they were immersed in hot
water for 3 minutes. Next, after shaking off the water,
t h e y  w e r e  i m m e r s e d  i n  l i q u i d  n i t r o g e n  f o r  3  m i n u t e s .
After 10 such cycles, the picowell substrates were care-
fully examined via an atomic force microscope and scan-
ning electron microscope. The substrate structure was
found to be intact, including its sharp edges (< 0.1 μm
thick) and tips, and its smooth surface. No breaks or
small crevices could be observed.
Durability of the i3C in the freezing-thawing cycles
Unlike the monolithic glass chip, the complete i3C is con-
structed of several materials, which have differentDeutsch et al. BMC Cell Biology 2010, 11:54
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thermo-mechanical characteristics. Indeed, the i3C
design included thermal expansion clearances between
adjacent components. However, the durability tests were
designed to best reflect the intended use in our experi-
ments. The endurance tests included three repetitions of
freezing, thawing and incubating cycles: first, the i3C was
loaded at room temperature with a total volume of 12.5 μl
of concentrated BO21 in PBS solution (BO21 is a very
strong dye that can be easily observed). It was then placed
in a -80°C freezer for 1 hour, without any pre-cooling.
Next, the i3C was placed over white filter paper to test for
leakage. In the leakage test, the i3C was allowed to dry
and the paper was inspected for staining marks resulting
from leaks. Finally, the i3C, loaded with BO21 and placed
in a closed Petri dish, was incubated overnight at 37°C in
full humidity. The leakage test was performed again as
described. All the tests showed no observable leakage.
The i3C thus proved reliable during all the experiments,
including freezing down to -80°C and thawing to room
temperature.
Complementary i3C-durability tests were performed
under extreme conditions as well (not shown here).
Briefly, a procedure similar to that described above was
used except that the BO21-filled i3C was placed in a small
metal box with an embedded thermo-couple sensor and
placed into liquid nitrogen. Similar to the experiment
with cells, no direct contact was made between the i3C
and liquid nitrogen. It took just a few seconds for the
measured temperature in the box to reach its steady-
state: -153°C. Then, after 10 minutes in liquid nitrogen,
the metal box was taken out of the liquid nitrogen, and
the frozen i3C was removed from the box. The latter was
placed on a clean dry white lab paper, in ambient room
temperature for 10 minutes. During this period, the dye
in the i3C was fully thawed. Then, the i3C was checked
for intactness and leakage as described above.
These freezing - thawing test cycles were repeated 7
times on 3 separate, identical i3Cs. The test results indi-
cate that all three tested samples remained intact, and no
signs of leakage were detected.
Cell maintenance during the freezing-thawing cycle
Under the controlled experimental conditions described
above, the majority of cells was found to be maintained in
their picowells throughout the freezing - thawing cycle
and associated manipulations. A detailed description of a
representative cell monitoring experiment is given in Fig-
ure 5. The figure includes 7 images of the same field of
picowells in the i3C, acquired during the freezing - thaw-
ing cycle. The blue and red fluorescences mark the cell
nucleus and cytoplasm respectively. This facilitates the
identification of the same individual cells when compar-
ing different images obtained in the experiment. In the
present study, a total of 5 such comprehensive experi-
ments were performed. They indicate that more than 97%
of cells were retained in their original picowells (dislodg-
ing < 3%), during the entire freezing - thawing cycle and
medium exchange process (Figure 6). Comparing cell
locations before the freezing - thawing cycle (step 1) to
those that follow it (steps 2-4) showed a significant differ-
ence (P < 0.04). However, no statistically significant dif-
ference (P = 0.7-0.8) in cell locations was found when all
post-freezing - thawing cycle steps were compared. These
findings clearly indicated that the main cause for cell dis-
lodging is closely related to the freezing - thawing mecha-
nism.
A similar dislodging percentage was found when the
cell-loaded i3C was stored in Revco or in a nitrogen stor-
age tank. Moreover, although the cells may dislodge dur-
ing the freezing - thawing cycle, whether performed in
the cryostage, Revco or nitrogen storage tank (the latter
concerns a few cases carried out in this study), they do
not dislodge during the further post thawing steps, since
the hosting media after thawing is completely converted
to a single phase, liquid medium (data not shown).
Apart from these findings, several important practical
conclusions were reached regarding the factors influenc-
ing cell dislodging (with reference to U937 cells). Gener-
ally, the more properly the cells settle (at the base of a
picowell), the more spatially stable they are and, conse-
quently, the better they accommodate the forces they are
subjected to during the freezing - thawing cycle and
medium exchange. Briefly, the factors affecting cell dis-
lodging are the following:
- Suspending medium. The loading of cells into picow-
ells when the cells are suspended in PBS rather than in
the cryopreservation medium favors complete cell sedi-
mentation and decreases their dislodging, most likely due
to surface tension forces [20,21].
- Loading medium. Cells must be loaded into picowells
while suspended in PBS. The loading of cells that had pre-
viously been suspended in the cryopreservation medium
always resulted in an increased percentage of cell dislodg-
ing, presumably due to the higher density (relative to that
of PBS) of the medium.
- Settling time. Just after ~10 minutes of cell sedimenta-
tion, the initial suspending PBS medium can be
exchanged by the cryopreservation medium.
- Cell concentration. This should be adjusted so that a
picowell would be occupied by a single cell only. Nor-
mally, the first cell to enter a picowell holds the base, forc-
ing the next cell to enter the picowell at a higher position,
from which it can be dislodged during the freezing -
thawing cycle and medium exchange.
- Heating by illumination. The absorption of transmit-
ted light by the cells and their surroundings is a cause of
cell dislodging due to heat agitation. This phenomenon
can be considerably reduced by filtering out far-red and
near-infrared light. Generally and expectedly, the excita-Deutsch et al. BMC Cell Biology 2010, 11:54
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tion light used for fluorescence measurements was not
found to affect cell dislodging.
Cell viability following the freezing-thawing cycle
Under the present controlled experimental conditions,
the majority of cells remained alive in their picowells after
the freezing - thawing cycle and associated manipula-
tions. Figure 7 shows three representative transmitted
and fluorescence light images (of FDA and of PI stained
cells) in the same field of picowells. All the images were
acquired after a freezing - thawing cycle, the opening of
the cryostage lid, and exchange of the cryopreservation
medium with a mixture of FDA and PI for vitality assess-
ment, according to the procedure described above. As the
figure demonstrates, most of the cells retained their
membrane integrity.
Altogether, 24 experiments were performed to examine
cell viability after slow and fast freezing in the freezing -
thawing cycle, for cells maintained in the i3C and in a
cryo-vial. Samples that did not undergo a freezing - thaw-
ing cycle were used as controls. The results are shown in
a histogram in Figure 8. The results indicate that, after
slow freezing and thawing, the viability of U937 cells
within the i3C was the same as in control cells which
underwent freezing in standard cryo-vials (the percent-
ages of dead cells were 8.66% ± 3.5 in the i3C and 9.1% ±
5.6 in standard vials). With reference to controls, the
comparison between the cryo-mini-vials (in the cry-
ostage) and the (standard) cryo-macro-vials (in the cryo-
box) showed no detectable differences.
Figure 5 Monitoring cell retention during the cell freezing - thawing cycle. U937 cells, labeled with the Hoechst dye (blue fluorescence) and 
Quantum Dots (red fluorescence), were loaded into the i3C and then underwent a freezing and thawing cycle, which included the following docu-
mentation steps: first, before closing the cryostage lid; (A) transmitted light image is superimposed with the fluorescence image of the same field (B). 
Next, images were taken after closing the cryostage lid (C) and following the pre-cooling step (D), after which freezing was performed. Immediately 
after thawing, while the lid was still closed, transmitted light (E) and fluorescence (F) images were acquired. To assess the vitality of the same thawed 
cells, we examined their ability to hydrolyze FDA by exchanging their cryo-media with FDA staining media: 7.5 μm of FDA staining solution was intro-
duced to the conduit basin of the i3C (when the i3C was in the cryostage chamber), and then (after a few minutes) the fluorescence of the FDA-stained 
cells was imaged (G). Note that the majority of cells retain their spatial location. The red arrow indicates a single cell that changed location after thaw-
ing. Bars: 25 μm.Deutsch et al. BMC Cell Biology 2010, 11:54
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After fast freezing, the variation in cell viability was
high. However, while most of the cells did not survive this
protocol within the 25 μl micro-vials, a significantly high
proportion of cell viability was evident when U937 cells
were frozen under the same fast cooling protocol within
the i3C (the percentages of dead cells were 16.4% ± 12.8
in the i3C and 48.6% ± 29.9 in micro-vials, p < 0.01).
Interestingly , in a limited number of cases, where cell-
loaded i3Cs were stored in a nitrogen storage tank, no
observable differences were found between the three
freezing procedures: cryostage, Revco refrigerator and
nitrogen storage tank, regarding the maintenance of cells
in the picowells and their membrane integrity.
Discussion
The present study uniquely demonstrates a new, highly
promising approach in cryopreservation, especially suc-
cessful for the cryopreservation of untethered cells that
do not undergo additional treatments in order to avoid
cell dislodging. The ability to maintain individual unteth-
ered cells in their original positions during the freezing/
thawing/post-thawing procedures is the unique feature of
this approach which fundamentally distinguishes it from
existing devices [11]. This ability was demonstrated on
untethered human promonocytic U937 cells under stan-
dard laboratory conditions. The heart of this approach is
the use of picowell substrates which, to the best of our
knowledge, is the first (and presently the only) means that
will enable the preservation of intact cells' identity, at the
resolution of individual cells, during the freezing and
thawing cycle, including medium exchange. Freezing sub-
strates for single cells had been used before [11,19] but
lacked either the optical access or microfluidic device
that would enable medium exchange without removing
the cells. Live-cell bio-banks utilize heterogeneous cell
populations whose functional properties need to be pre-
Figure 6 Cell retention. Box plot of the percentage of dislodging 
cells during the freezing - thawing cycle. U937 cells were loaded 
into the i3C (n = 5), and the same area (20 × 20 picowells) was imaged 
in the course of cell handling. Total cells dislodging was calculated af-
ter each step: 1 - after pre-cooling, 2 - immediately after thawing, 3 - 
post-thawing after opening the cryostage lid, 4 - after post-thawing 
medium exchange. The mean value for each data set is indicated by 
the central line and the first and third quartiles are the edges of the box 
area.
Figure 7 Monitoring cell viability after the freezing (slow cooling rate, 1°C per minute) and thawing cycle. Representative transmitted light (A) 
and corresponding fluorescent images of FDA (B) and PI (C) staining of U937 cells within the i3C after a freezing and thawing cycle. The red line con-
nects images of the only cell in the field found to be PI-positive. The blue arrow indicates a reference region in the picowell field at the bottom of the 
i3C chamber. Bars: 25 μm.
Figure 8 Cell viability after freezing and thawing within the i3C 
and in control standard cryo-vials. U937 cell populations underwent 
slow or fast freezing followed by thawing in either the i3C or cryo-vials, 
after which they were exposed, while residing in the i3C or the vial, to 
staining mixture of FDA and PI. The percentages of dead U937 cells (PI 
positive) are shown. Bars represent mean and SD values for at least 6 
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served. For example, peripheral blood mononuclear cells
must maintain their characteristic immune profile, hepa-
tocytes must preserve their metabolic activity [22], and
embryonic stem cells must retain their pluripotency after
cryopreservation [23]. Hence, successful cryopreserva-
tion relies on the ability to observe and retrieve a specific
functioning cell or cell group.
The high optical quality of the i3C, as opposed to cryo-
vials, enables the observation of samples in the course of
cryopreservation (e.g., cryomicroscopy and cryo-mul-
tiphoton microscopy [24]) and accompanying treatments.
This capability may open a new chapter in cryopreserva-
tion, addressing the need to select thawed cells according
to their pre-freezing characteristics and to compare pre-
and post-freezing - thawing cycle cellular features. More-
over, the i3C in effect acts as a multipurpose single cryo-
vial in which the sample (even a few precious cells,
instead of bulk-frozen materials) can be fully handled.
This method may involve sample preparation (e.g.,
medium exchange), freezing, thawing, post-thawing
treatment (e.g., washing off cryoprotectants, etc.), post-
thawing cell culturing and monitoring with no, or only
negligible, cell and time loss involved in finding or trans-
ferring specific cells. These capabilities make the i3C an
ideal means to establish the optimal cryopreservation
protocols for various cell types, by defining the correla-
tion between specific cell functions and the optimal
retrieval of specific cells after their freezing and thawing.
Regarding the influence of the immediate cell environ-
ment (structure, space around the cell, vial material, etc.)
that surrounds the sample in cryopreservation, the i3C
appears to be dramatically superior to commercial micro-
vials in maintaining the viability of cells undergoing fast
cooling. Even though the statistical significance of this
finding is high, we cannot yet explain it completely. Gen-
erally, the surface to volume ratio and the geometry of the
cryo-vessel influence the heat ablation, ice crystallization
and the extent of possible super-cooling. However, in this
case, the properties of the i3C substrates are advanta-
geous for fast cooling (40°C/min). However, in spite of
this advantage, the SD of post-thawing cell-death per-
centage is quite high. The reason for that is intrinsic.
Generally, during the freezing of a water solution, the
osmollality of the liquid phase is elevated due to the ele-
vation of solutes' concentration. This includes the objects'
concentration (such as cells). Consequently, cells in the
liquid phase are actually immersed in a liquid, whose sol-
ute concentration increases during freezing. Conse-
quently, intracellular water flows from the cells to the
hosting solution. In other words, the cells are dehydrating
during freezing. Since the freezing of intracellular water
damages the cell, the more water leaves the cell before cell
freezing, the higher the probability the cell will be pre-
served through the freezing - thawing cycle, remain alive
and properly functioning [25,26]. When slow freezing is
applied, intracellular water may have enough time to
leave the cell before it freezes. On the other hand, with
fast freezing, ice formation in the hosting media consid-
erably precedes cell dehydration. This results in intracel-
lular water freezing and consequently cell death [27].
Actually, the velocity of ice crystal growth is temperature-
dependent. The lower the temperature, the faster the
growth rate of ice crystals. This leaves the cells less time
to dehydrate [28]. For practical purposes, this may be
interpreted as if each nucleation temperature results in a
"characteristic cell-death percentage."
Next, considering the SD of cell-death percentage,
obviously, the more stable the procedure, the lower the
resulting SD. When a slow freezing protocol is con-
cerned, the observed nucleation temperature is quite
constant: about -15 to -20°C (when using 5-10% DMSO).
Obviously, this results in a quite repeatable chain of
events occurring during freezing, thus yielding a rela-
tively small SD with reference to the cell death percent-
age. This is not the case with fast freezing. In contrast to
slow freezing, the nucleation temperature is difficult to
predict. It may actually vary between -10°C and -40°C.
Having established that each nucleation temperature
results in its own cell-death percentage, it is expected that
fast freezing protocols will yield a relatively high SD.
The micro-vials are designed for automatic application
of Me2SO which, if included, drastically increases the
post-thawing viability of the islets of Langerhans. The
mode of application of the cryoprotectant also affects the
survivability, so the slow and careful microfluidic
medium exchange may contribute to good viability.
These experiments provide a first indication for accept-
ably successful cryopreservation performance of the i3C
substrate in comparison to other cryo-substrates. Further
experiments are necessary to define the direct causes for
their similarities and differences.
Regarding the choice of controls in this study, since this
study concerns small cells and many such cells, the sug-
gested i3C methodology is not comparable with vitrifica-
tion protocols, including cryoloops. On the one hand, the
latter are usually intended for fast freezing cryopreserva-
tion of only one or a few cells (mostly large and highly
valuable cells) and therefore are appropriate for small vol-
umes and require high heat transfer. On the other hand,
the i3C is designed to maintain the identity of each indi-
vidual cell among hundreds, up to millions of small cells,
in the same vessel, during the freezing - thawing cycle.
Hence, by and large, slow freezing protocols are more
suitable for the freezing - thawing cycle performed in the
i3C. For this reason we chose for control probably the
most widely-used cryo-vessel for cell culture at the
moment, the 1 ml cryo-vial, and not cryoloops. Regard-Deutsch et al. BMC Cell Biology 2010, 11:54
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ing cell retrieval, we found the third procedure described
in the "cell retrieval" section to be the most convenient.
Other versions of the i3C are now under construction
and/or testing, including adjustments for cryopreserva-
tion of large cells, for example oocytes and cell clusters
such as spheroids and embryonic bodies. In practice,
experiments with oocytes are performed in a specially
designed i3C-substrate for oocytes, termed the i3CO
(report in preparation). It is the outcome of diverse adap-
tations to the present i3C and takes into account the size
of oocytes, minimal substrate mass and ease of access to
oocytes. The oocyte-adjusted picowell has an average
opening diameter and depth of ~260 μm and 175 μm (cf.
the 20 μm and 8 μm in the present i3C picowells sub-
strate, correspondingly). The new substrate contains only
16 (4 × 4) adjusted picowells, since normally the sample
(from the same patient) does not exceed 10 oocytes. Con-
sequently, the mass of the i3CO substrate is about 35
times smaller than that of the present substrate, the i3C.
This fact makes the i3CO a low heat capacity configura-
tion, compatible with fast cooling procedures. Obviously,
an array of large picowells, such as those of the i3CO,
might be used for cryopreservation of cells that are stored
in populations, e.g. stem cells.
Furthermore, experiments are being conducted to
include the picowell and capillary system in cryo-vials
which are especially designed for modern bio-banking
(e.g., the "Icebreaker" [29]). Finally, it should be empha-
sized that, since the present study is a methodological
one, the feasibility of the i3C was shown by the use of
U937 cells only. Moreover, their durability during a cryo-
preservation cycle, while residing in the i3C, was deter-
mined only by examining their plasma membrane
integrity by PI and FDA double-staining. However, due to
the importance and broadness of the issue of cell func-
tionality after thawing in the i3C, a comprehensive study
has been performed and will be reported separately. In
that study, 5 major cell functionality tests were con-
ducted. Briefly, these included: (a) Annexin V versus PI
staining for apoptosis and cell death identification; (b)
Mitochondrial membrane potential recovery assessed by
TMRM staining; (c) Cytoplasm membrane integrity
assessed by fluorescein accumulation; (d) Intracellular
metabolism tested by FDA staining kinetics; and (e) Cell
proliferation. These measurements were all performed
both after short (up to 6 hours) and long (up to 48 hours)
durations after thawing. Most of these measurements
show results similar to those obtained with standard
cryo-vials and mini-vials. The remainder show a better
performance.
Conclusion
The results of the present study offer new opportunities
for cryopreservation. Using the present methodology, the
cryopreservation of individual identifiable cells, and their
observation and retrieval at an individual cell resolution
become possible for the first time. This approach facili-
tates the correlation between cell characteristics before
and after the freezing and thawing cycle. Thus, it is
expected to significantly enhance current cryopreserva-




Propidium iodide (PI) and dimethyl sulfoxide (Me2SO)
were obtained from Sigma-Aldrich (St. Louis, MO, USA).
Fluorescein diacetate (FDA) was purchased from Sigma-
Riedel-de-Haen (Hanover, Germany). Hoechst 33342 tri-
hydrochloride trihydrate dye was purchased from Invit-
rogen-Molecular Probes (Carlsbad, CA, USA). InGaP/
ZnS Evi Tags Quantum Dots (QD), 25 nm hydrodynamic
diameter, excitation/emission spectra < 543/650 nm,
were obtained from Evident T echnologies Inc. (eBiosci-
encs Inc, Troy, NY, USA). RPMI-1640 medium, heat-
inactivated fetal calf serum, penicillin, streptomycin, glu-
tamine, sodium pyruvate and HEPES (all for complete
medium) were obtained from Biological Industries (Kib-
butz Beit Haemek, Israel).
Cell culture
Human pro-monocytic U937 cells (ECACC, UK) were
maintained in RPMI-1640 medium supplemented with
10% heat-inactivated fetal calf serum, 100 U/mL penicil-
lin, 100 μg/mL streptomycin, 2% glutamine, 2% sodium
pyruvate and 2% HEPES. Cells were maintained in com-
pletely humidified air with 5% CO2 at 37°C. Before use,
exponentially growing cells were obtained, washed and
re-suspended in PBS at a concentration of 1.5-2.5 × 106
cells/ml.
Durability tests
The durability of picowells after the freezing - thawing
cycle was examined via an atomic force microscope
(AFM - Nano W izard II AFM, JPK Instruments, Berlin,
Germany) and scanning electron microscope (SEM -
Inspect F50, FEI Company, Hillsboro, OR, USA).
Cell staining
For easy tracing of cells in the durability experiments, the
nucleus was stained by Hoechst 33342 dye (5 μg/ml) in
PBS for 1 hour at RT, in the dark. Hoechst 33342 is a very
well known vital dye that does not affect cell viability
when proper dye concentration and staining duration are
used [30-32]. For cell labeling with QD, U937 cells (1.5-
2.5 × 106 cells/ml) were incubated in the presence of 25
pM QD solution (this concentration was found to be non-
toxic), in complete RPMI medium at 37°C for 3-48 hoursDeutsch et al. BMC Cell Biology 2010, 11:54
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in a completely humidified atmosphere with 5% CO2. At
the end of incubation, cells were washed with fresh
medium and re-suspended in PBS.
In order to determine plasma membrane integrity for
the cell viability assay, cells were double-stained with PI
and FDA. A mixture of FDA (final concentration 1.2 μM)
and PI (final concentration 2.5 μg/ml) was added to U937
cells loaded into the i3C, for 5 minutes in the dark, at RT
(the method is similar to that reported by Ehrhart et al.
2009 [33]). The cells were then imaged using fluorescence
cubes for fluorescein and PI.
Statistical analysis
For each experiment, 2-3 i3C devices were used. For each
i3C device, 5 images from 5 different areas were acquired
(about 800-1000 individual cells). Each area was imaged 4
times: before freezing, immediately after thawing, after
cryo-stage opening and following medium exchange, as
described in the section "Evaluation of the i3C ability to
retain cells during FTC - the experimental procedure."
The mean and SD for each measured parameter were cal-
culated for the different cell populations under investiga-
tion (control and experiment). Comparisons between cell
groups (controls and experiments) were carried out using
the ANOVA test for small sample groups. All the values
are represented as average ± SD.
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